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regulating these processes. One interesting event thatand Howard Hughes Medical Institute
occurs during the differentiation of DP thymocytes intoUniversity of Washington
both the CD41 and CD81 SP lineages is the acquisitionSeattle, Washington 98195
of resistance to glucocorticoids. DP thymocytes are ex-
quisitely sensitive to glucocorticoid-induced apopto-
sis, whereas SP thymocytes are relatively resistantSummary
(Scollay et al., 1984; Screpanti et al., 1989; Cohen, 1992).
The molecular basis for this difference in glucocorticoidThe Notch receptor and its ligands are involved in
sensitivity is not known. Glucocorticoids, produced bothmany developmental processes. They are highly ex-
by the adrenal gland and endogenously within the thy-pressed in the thymus and have been implicated in
mus, have complex effects on the development of thy-the CD4 versus CD8 lineage decision. We identified the
mocytes (Vacchio et al., 1998). Since circulating levels
constitutively active intracellular fragment of murine
of corticosteroids approach that which causes apopto-
Notch-1 as capable of rendering thymomas resistant sis in vitro, it is hypothesized that glucocorticoids may
to glucocorticoid-induced apoptosis. This effect was contribute to the process of death by neglect of DP
confirmed in other T cell lines and in CD41CD81 DP thymocytes and that the acquisition of resistance to
thymocytes. Activation of the Notch signaling pathway glucocorticoids is a key event that rescues thymocytes
also upregulated a number of other markers that, like from apoptosis during positive selection (Sprent et al.,
steroid resistance, correlate with DP maturation into 1988; Cohen, 1992).
both the CD4 and CD8 lineages. These results suggest To further our understanding of molecular events as-
that Notch signaling is critically involved in the matura- sociated with thymocyte maturation, we sought to iden-
tion of DP thymocytes into both CD41 and CD81 SP tify molecules that regulate thymocyte sensitivity to
thymocytes. glucocorticoids. For this purpose, we screened a thymo-
cyte cDNA library for genes that confer glucocorticoid
Introduction resistance in a glucocorticoid-sensitive DP thymoma
cell line. This approach led to the repeated identification
The differentiation of immature DP thymocytes into ma- of the intracellular domain of mNotch-1. Notch is an
evolutionarily conserved cell surface receptor that regu-ture CD41 and CD81 SP thymocytes is a highly regulated
lates changes in gene expression during developmentprocess. DP thymocytes, which express T cell receptor
(Artavanis et al., 1995). Following productive interaction(TCR) and both CD4 and CD8 coreceptor molecules, are
with ligands such as Jagged, Notch undergoes cleavageevaluated for their ability to recognize self-peptide/MHC
within the transmembrane domain, allowing the intracel-ligands expressed on thymic epithelial cells. DP thymo-
lular portion to traffic to the nucleus (Schroeter et al.,cytes that express a TCR with too-low affinity for self-
1998; Struhl and Adachi, 1998). In many systems, ec-peptide/MHC undergo apoptosis by a process termed
topic expression of the intracellular domain of Notchªdeath by neglect.º DP thymocytes that express a TCR
(NotchIC) results in constitutive activation of the Notchwith too-high affinity for self-peptide/MHC undergo apo-
signaling pathway (Lieber et al., 1993; Rebay et al., 1993;ptosis by a process termed ªnegative selection.º In con-
Struhl et al., 1993). Mice expressing NotchIC as atrast, DP thymocytes that express TCR with an interme-
transgene in the thymus develop an excess of CD81 SPdiate affinity for self-peptide/MHC are rescued from
thymocytes relative to CD41 SP thymocytes (Robey etapoptosis and differentiate into mature SP thymocytes
al., 1996). This led to the suggestion that the CD4 versusby a process termed ªpositive selectionº (for review see
CD8 lineage choice following a positively selecting inter-Kisielow and von Boehmer, 1995; Jameson and Bevan,
action with MHC ligands is determined by Notch signal-1998). This step in thymocyte maturation also involves
ing. According to this idea, MHC class I recognitiona choice between differentiation into either the CD41 or
leads to Notch signaling while MHC class II recognition
CD81 SP lineages. DP thymocytes that recognize MHC
allows DP thymocytes to avoid Notch signaling.
class I ligands during positive selection downregulate We show here that activation of the Notch signaling
CD4 expression and acquire the ability to mediate cyto- pathway in T cell lines and in thymocytes induces multi-
toxic effector functions, whereas DP thymocytes that ple events that are associated with the maturation of
recognize MHC class II ligands downregulate CD8 ex- DP thymocytes into SP thymocytes. These include the
pression and acquire the ability to mediate helper ef- acquisition of resistance to glucocorticoids and the
fector functions. upregulation of Bcl-2, TCR, and Deltex expression. Im-
Our understanding of positive selection and lineage portantly, these phenotypic changes occur during the
commitment is based primarily on the characterization differentiation of DP thymocytes into both the CD4 and
of requisite TCR and CD4 and CD8 coreceptor signals CD8 lineages. These results lead us to propose that
activation of the Notch signaling pathway is a crucial
event in the maturation of both CD41 and CD81 SP thy-* To whom correspondence should be addressed (e-mail: mbevan@
u.washington.edu). mocytes.
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(Figure 1C). The pMI retroviral vector used in these ex-
periments allows identification of transgene-expressing
cells by cell-surface expression of human CD2 (see Ex-
perimental Procedures). Infection of AKR1010 and 2B4.11
with retrovirus prepared from the pMI/NotchIC vector
resulted in 20%±30% transgene-expressing cells (Fig-
ure 2A, top panels). These populations were cultured in
medium alone or in medium containing dexamethasone
for 7 days. When cultured in medium alone, there was
a gradual loss of transgene-expressing cells, suggesting
that expression of NotchIC may confer a growth disad-
vantage to these T cells (Figure 2A, middle panels). In
contrast, when cultured in the presence of dexametha-
sone, there was a dramatic loss of uninfected cells, while
transgene-expressing cells selectively survived (Figure
2A, bottom panels). In control experiments using cells
infected with the empty pMI vector, there was no loss of
hCD2-expressing cells in medium alone and few viableFigure 1. Identification of NotchIC as a Mediator of Resistance to
cells remaining in cultures containing dexamethasoneGlucocorticoids in T Cells
(data not shown). This confirms that expression of NotchIC(A) Schematic representation of the mNotch-1 amino acid sequence.
Labeled are the transmembrane domain (TM), residues 1724±1746; confers resistance to glucocorticoids in multiple T cell
the RAM domain, residues 1751±1806; the ankyrin domain, residues lines.
1865±2075; and the PEST domain, residues 2481±2503 (del Amo et Glucocorticoids induce both cell cycle arrest and apo-
al., 1993; Tamura et al., 1995). The majority of the extracellular do-
ptosis in susceptible T cells (Zacharchuk et al., 1990;main has been omitted.
Miyashita and Reed, 1992). The survival of AKR1010(B) Schematic representation of the coding regions of mNotch-1
and 2B4.11 cells in the presence of dexamethasonecDNAs identified by expression cloning. Numbers indicating the
amino- and carboxyl-terminal amino acid residues are based on suggests that expression of NotchIC inhibits both of
conceptual translation of the cDNA sequences. The initiation methi- these effects. To confirm this, we generated polyclonal
onine for these cDNAs has not been determined. RH, US, and OT cell lines derived from AKR1010 and 2B4.11 that express
refer to clones derived from these respective thymocyte cDNA li-
NotchIC by infecting with retrovirus prepared from thebraries.
pMI/NotchIC vector and panning for cells that express(C) Schematic representation of the regions of mNotch-1 cloned
hCD2. Cell cycle analysis of these and control cells wasinto the pMI retroviral vector and transferred into the AKR1010 and
2B4.11 T cell lines for functional assays. NotchIC begins at the first performed following exposure to dexamethasone (Fig-
amino acid of the RAM domain. NotchIC/mM2-2 contains a mutation ures 2B and 2C). Dexamethasone causes AKR1010 cells
in the RAM domain that disrupts RBP/Su(H) binding (Tamura et al., to arrest in the G1 phase of the cell cycle as indicated1995). NotchIC/DAnk begins immediately amino terminal to the third
by the accumulation of cells with a diploid DNA content.ankyrin repeat of Notch.
This is followed by the gradual emergence of apoptotic
cells with a subdiploid DNA content (Figure 2B). In con-
Results trast, AKR1010 cells expressing NotchIC do not undergo
cell cycle arrest or apoptosis in response to dexametha-
Expression of the Intracellular Domain of mNotch-1 sone. Similarly, dexamethasone induces 2B4.11 cells to
Confers Resistance to Glucocorticoids in T Cells undergo apoptosis, and this is inhibited by expression
We employed an expression cloning strategy to identify of NotchIC (Figure 2C). These results confirm that ex-
genes that regulate thymocyte sensitivity to glucocor- pression of NotchIC inhibits both glucocorticoid-induced
ticoids. A thymocyte cDNA library was constructed apoptosis and cell cycle arrest in T cells. In contrast,
in a retroviral vector (Onishi et al., 1996) and transferred expression of NotchIC has no effect on apoptosis in-
into the glucocorticoid-sensitive DP thymoma cell line, duced by staurosporine, ceramide, or etoposide (data
AKR1010, followed by selection for clones that prolif- not shown). Additional experiments indicated that NotchIC
erate in the presence of dexamethasone. Retrovirally has no effect on expression of the glucocorticoid recep-
transferred cDNAs from glucocorticoid-resistant clones tor or the induction of multiple glucocorticoid-regulated
were sequenced, and multiple independent clones were genes in these cell lines (data not shown).
found to express cDNAs derived from the mNotch-1
gene (Figures 1A and 1B). Conceptual translation of the
cDNAs identified by expression cloning indicates that Resistance to Glucocorticoids Correlates with
Activation of the Notch Signaling Pathwaythey encode polypeptides corresponding to the intracel-
lular domain of mNotch-1. Since ectopic expression of and Maps to the RAM Domain of mNotch-1
In many cell lineages, activation of the Notch signalingthe intracellular domain of Notch results in constitutive
activation of the Notch signaling pathway (Lieber et al., pathway results in the upregulation of Notch expression
in a positive feedback loop (Wilkinson et al., 1994; Luo1993; Rebay et al., 1993; Struhl et al., 1993), this sug-
gested that Notch signaling confers resistance to gluco- et al., 1997; Weinmaster, 1997). We performed Western
blot analysis to determine whether expression of NotchICcorticoids in T cells. To confirm this, the intracellular
domain of mNotch-1 was expressed in AKR1010 and in induces this downstream effect of Notch signaling in T
cells (Figure 3A). Both AKR1010 and 2B4.11 express lowthe glucocorticoid-sensitive T cell hybridoma, 2B4.11
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Figure 2. Expression of NotchIC Confers Resistance to Glucocorticoid-Induced Apoptosis and Cell Cycle Arrest in T Cells
(A) Expression of NotchIC in AKR1010 and 2B4.11 confers resistance to dexamethasone. AKR1010 and 2B4.11 were infected with retrovirus
derived from the pMI/NotchIC vector. Following infection, transgene-expressing cells were identified by FACS analysis for IRES-driven hCD2
expression. The cells were then cultured in medium alone or in medium containing 1027 M dexamethasone for 7 days followed by staining
for hCD2 expression. Numbers represent the percentage of transgene-expressing cells in the indicated gates.
(B) Expression of NotchIC confers resistance to glucocorticoid-induced apoptosis and cell-cycle arrest in AKR1010. Control cells and polyclonal
AKR1010 cells expressing NotchIC were cultured in the presence of 1027 M dexamethasone for the indicated times and analyzed for DNA
content by FACS. Numbers represent the percentage of cells in the indicated gates.
(C) Expression of NotchIC confers resistance to glucocorticoid-induced apoptosis and cell cycle arrest in 2B4.11. Control cells and polyclonal
2B4.11 cells expressing NotchIC were assayed for sensitivity to glucocorticoid-induced apoptosis and cell cycle arrest as in (B).
levels of mNotch-1. In contrast, polyclonal AKR1010 and other experimental systems, deletion or mutation of the
RAM domain similarly reduces, but does not eliminate,2B4.11 cells expressing NotchIC express high levels
of endogenous mNotch-1. The two mNotch-1 species RBP/Su(H)-mediated transcriptional activation (Kato et
al., 1997; Wettstein et al., 1997). In contrast, expressionthat are upregulated represent the full-length z300 kDa
and the proteolytically processed z120 kDa forms of of NotchIC/DAnk, which contains a deletion of the RAM
domain and the first two ankyrin repeats, does not con-mNotch-1 (Kopan et al., 1996; Blaumueller et al., 1997).
This suggests that expression of NotchIC activates fer on 2B4.11 the ability to proliferate in the presence
of dexamethasone. Similar results were obtained withdownstream events of the Notch signaling pathway in
these T cells. Together with the ability of NotchIC ex- the AKR1010 cell line (data not shown). These results
suggest that downstream events of the Notch signalingpression to inhibit glucocorticoid-induced apoptosis
and cell cycle arrest, these data suggest that activation pathway leading to glucocorticoid-resistance are medi-
ated by RBP/Su(H).of the Notch signaling pathway confers resistance to
glucocorticoids in T cells.
Notch signaling regulates gene expression by activat- Activation of the Notch Signaling Pathway
Upregulates Bcl-2 Expression in T Cellsing the RBP/Su(H) transcription factor (Artavanis et al.,
1995). This requires the RAM and ankyrin domains of The mechanism by which glucocorticoids induce apo-
ptosis in thymocytes is not understood. GlucocorticoidsNotch (Kato et al., 1997). In some cases, however, down-
stream effects of Notch signaling may be mediated by bind to the glucocorticoid receptor (GR) and either acti-
vate or inhibit gene expression (Beato et al., 1995). Glu-RBP/Su(H)-independent mechanisms (Shawber et al.,
1996; Matsuno et al., 1997). To address whether resis- cocorticoid-induced apoptosis requires de novo RNA
and protein synthesis and is dependent on the DNA-tance to glucocorticoids is mediated by RBP/Su(H), we
assayed Notch constructs that lack functional RAM and binding domain of the GR (Cohen and Duke, 1984; Wyllie
et al., 1984; Reichardt et al., 1998). This suggests thatankyrin domains (Figure 1C) for their ability to confer
resistance to glucocorticoids. To quantitate this effect, glucocorticoids induce the expression of genes that ac-
tivate the apoptotic pathway. One determinant of sus-the proliferative rate of 2B4.11 cells following culture in
the presence of dexamethasone was measured (Figure ceptibility to glucocorticoids is the Bcl-2 family of pro-
teins. Overexpression of Bcl-2 or Bcl-XL in T cells inhibits3B). Expression of NotchIC, which contains functional
RAM and ankyrin domains, allows the proliferation of glucocorticoid-induced apoptosis but not cell cycle ar-
rest (Sentman et al., 1991; Strasser et al., 1991; Siegel2B4.11 in the presence of dexamethasone. Expression
of NotchIC/mM2-2, which contains point mutations in et al., 1992; Miyashita and Reed, 1992; Chao et al., 1995;
Grillot et al., 1995). We performed Western blot analysisthe RAM domain that inhibit RBP/Su(H) interaction, also
allows proliferation in the presence of dexamethasone to determine whether expression of NotchIC affects the
expression of Bcl-2 or Bcl-2 family members (Figurebut at reduced levels relative to wild-type NotchIC. In
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Figure 4. Western Blot Analysis of Bcl-2 and Bcl-XL Expression in
AKR1010 and 2B4.11 Cells Expressing NotchIC
Lysates from the indicated cell lines were analyzed by Western blot
analysis for Bcl-2 expression. The blots were then stripped and
reprobed for Bcl-XL. Analysis of two additional dexamethasone-
resistant AKR1010 clones isolated by expressing cloning gave iden-
tical results to the RH4 clone.
DP thymoma cell line. Both of these events occur during
the differentiation of DP thymocytes into SP thymocytes.
This suggests that activation of the Notch signaling
pathway may induce multiple events associated with
thymocyte maturation. We therefore sought to identify
additional phenotypic changes induced by Notch signal-
ing in AKR1010. One important event that occurs during
the differentiation of DP thymocytes into SP thymocytes
Figure 3. NotchIC-Mediated Resistance to Glucocorticoids Corre- is the upregulation of TCR expression. To determine
lates with Activation of the Notch Signaling Pathway and Maps to
whether expression of NotchIC upregulates TCR ex-the RAM Domain of Notch
pression, we infected AKR1010 with retrovirus prepared(A) Expression of NotchIC upregulates endogenous mNotch-1 ex-
from the pMI/NotchIC or control vector and assayedpression in AKR1010 and 2B4.11. Vector control cells and polyclonal
transgene-expressing cells for CD3 and abTCR expres-AKR1010 and 2B4.11 cells expressing NotchIC were analyzed for
endogenous mNotch-1 expression by Western blot analysis. sion by FACS. Uninfected AKR1010 and AKR1010 in-
(B) Resistance to glucocorticoids in T cells is mediated by the RAM fected with retrovirus prepared from control vector do
and ankyrin domains of mNotch-1. Polyclonal 2B4.11 cell lines ex- not express detectable TCR on their surface (Figure 5A,
pressing the different NotchIC constructs diagrammed in Figure 1C
left panels). Remarkably, AKR1010 cells infected withwere incubated in increasing concentrations of dexamethasone for
retrovirus prepared from the pMI/NotchIC vector ex-24 hr and their proliferation measured by 3H thymidine incorporation
press high levels of TCR of their surface (Figure 5A, rightduring an additional 12 hr of culture. Expressed is the percentage
of proliferation relative to cells cultured in the absence of dexameth- panels). To determine the dose-response relationship
asone. Counts incorporated in the absence of dexamethasone are between NotchIC expression and TCR upregulation, we
62158 6 2686 cpm for NotchIC; 65778 6 3759 cpm for NotchIC/ gated on different levels of hCD2 expression in poly-
mM2-2; 72343 6 4864 cpm for NotchIC/DAnk; and 89784 6 2942
clonal AKR1010 cells expressing NotchIC and analyzedcpm for vector alone.
these for TCR expression (Figure 5B). Interestingly, in-
creasing the level of NotchIC expression leads to a
greater percentage of cells expressing TCR rather than4). Polyclonal AKR1010 cell lines expressing NotchIC
an increase in the level of TCR expression. Furthermore,upregulate Bcl-2 expression 3-fold. Furthermore, in
TCR surface upregulation is partially dependent on thedexamethasone-resistant AKR1010 clones generated
RAM domain of mNotch-1, since mutation of the RAMby expression cloning, Bcl-2 is upregulated 10-fold. The
domain results in 5- to 10-fold fewer cells that expressdifference in the level of Bcl-2 upregulation may be due
TCR at the same level of transgene expression (Figureto differences in the level of transgene expression. In
5C). We also performed similar experiments to deter-contrast, expression of NotchIC does not upregulate
mine whether NotchIC expression affects CD4 or CD8Bcl-2 expression in 2B4.11 cells. No change in the ex-
coreceptor expression in AKR1010. While there was nopression of Bcl-XL or Bax is observed in either cell line
effect on CD4 expression, NotchIC downregulated CD8(Figure 4). These data suggest that Notch signaling can
expression approximately 5-fold (data not shown). Inter-upregulate expression of Bcl-2 in some T cell lines but
estingly, a similar level of CD8 coreceptor downregula-not in others. Furthermore, the ability of NotchIC to
tion also occurs during the transition of DP thymocytesconfer resistance to glucocorticoids in 2B4.11 without
into both the CD41 and CD81 SP lineages (Lucas andupregulating Bcl-2 expression indicates that this may
Germain, 1996).occur by a Bcl-2-independent mechanism.
Notch Signaling Regulates Deltex ExpressionActivation of the Notch Signaling Pathway
To further characterize downstream effects of NotchUpregulates TCR Expression
signaling in T cells, we sought to identify novel genesNotchIC expression confers resistance to glucocorti-
coids and upregulates Bcl-2 expression in the AKR1010 that are regulated by Notch signaling. For this purpose,
Notch Signaling during Thymocyte Development
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Figure 5. Expression of NotchIC Upregulates
TCR Expression
(A) Expression of NotchIC in AKR1010 in-
duces TCR surface expression. AKR1010 was
infected with retrovirus prepared from control
vector or the pMI/NotchIC vector. Two days
following infection, the cells were assayed for
IRES-driven hCD2 expression and CD3 ex-
pression by FACS analysis. Gates on unin-
fected and infected cells were established
based on hCD2 expression (top panels). Cells
falling in these gates were then analyzed for
CD3 expression (lower panels). Identical re-
sults were obtained using the H57-597 MAb
directed against the abTCR.
(B) Dose-dependent relationship between the
level of NotchIC expression and TCR expres-
sion. Vector control and polyclonal AKR1010
cell lines expressing NotchIC were stained
simultaneously for hCD2 expression and CD3
expression. Gates for different levels of hCD2
expression were established, and cells within
these were analyzed for CD3 expression. The
dotted line represents background staining
levels.
(C) Upregulation of TCR expression maps to
the RAM domain of Notch. Polyclonal AKR1010
cell lines expressing NotchIC, NotchIC/
mM2-2, or control vector were analyzed for
CD3 expression as in (B). The graph repre-
sents the percentage of cells expressing CD3
relative to the level of transgene expression.
we used the representation difference analysis (RDA) to glucocorticoids and express high levels of Bcl-2,
whereas DP thymocytes are sensitive to glucocorticoidstechnique (Hubank and Schatz, 1994) to identify genes
upregulated by expression of NotchIC in AKR1010. This and express low levels of Bcl-2 (Scollay et al., 1984;
Screpanti et al., 1989; Veis et al., 1993; Linette et al.,approach yielded multiple cDNA fragments derived from
the Deltex gene. Northern blot analysis confirmed that 1994). This also agrees with the expression pattern of
mNotch-1 in thymocyte subsets: Notch signaling posi-expression of NotchIC results in the upregulation of Del-
tex expression in AKR1010 (Figure 6A). Deltex was origi- tively regulates mNotch-1 expression in T cells, and
mNotch-1 is expressed at higher levels in DN and CD41nally identified in Drosophila melanogaster as a gene
that interacts with the Notch signaling pathway (Xu and and CD81 SP thymocytes relative to DP thymocytes
(Hasserjian et al., 1996).Artavanis, 1990). Homologs of Deltex have subsequently
been cloned from mice and humans (Pampeno and Mer-
uelo, 1996; Matsuno et al., 1998). Genetic and biochemi-
cal studies suggest that Deltex functions as a positive NotchIC Expression Confers Resistance
to Glucocorticoids in DP Thymocytesregulator of the Notch signaling pathway (Matsuno et
al., 1995). Our finding identifies Deltex as a novel target Our data indicate that activation of the Notch signaling
pathway in a DP thymoma cell line induces multipleof the Notch signaling pathway in T cells.
Since Deltex is positively regulated by Notch signaling phenotypic changes that are associated with the matu-
ration of DP thymocytes into SP thymocytes. To confirmin T cells, we reasoned that thymocytes that have active
Notch signaling would express Deltex whereas thymo- that similar effects occur in vivo, we analyzed DP thymo-
cytes from the NotchIC-9 mice, which express NotchICcytes that are not receiving Notch signals would lack
Deltex expression. Therefore, we analyzed FACS-sorted under the control of the lck proximal promoter (Robey
et al., 1996). Thymocytes from these mice and littermateDN, DP, CD41 SP, and CD81 SP thymocytes for Deltex
expression by RT-PCR (Figure 6B). Relatively high levels controls were cultured in the presence of dexametha-
sone and analyzed by FACS to determine their sensitivityof Deltex expression were detected in DN, CD41 SP,
and CD81 SP thymocytes, whereas much lower levels to glucocorticoids (Figure 7). As expected, DP thymo-
cytes from nontransgenic littermate control mice arewere detected in DP thymocytes. This pattern of Deltex
expression suggests that the Notch signaling pathway exquisitely sensitive to glucocorticoids. In contrast, DP
thymocytes from transgene-expressing NotchIC-9 miceis active in DN and CD41 and CD81 SP thymocytes and
inactive in DP thymocytes. Importantly, this agrees with are relatively resistant to glucocorticoid-induced apo-
ptosis. Therefore, activation of the Notch signaling path-our data indicating that glucocorticoid resistance and
Bcl-2 are positively regulated by Notch signaling since way confers resistance to glucocorticoids in both trans-
formed T cell lines and thymocytes.DN and CD41 and CD81 SP thymocytes are resistant
Immunity
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Figure 7. Expression of NotchIC Confers Resistance to Glucocorti-
coids in DP Thymocytes from Transgenic Mice
Thymocytes from NotchIC-9 and littermate control mice were incu-
bated in medium alone or medium supplemented with 1028 M dexa-
methasone for the indicated times and analyzed by FACS for viabilityFigure 6. Deltex Is Positively Regulated by Notch Signaling and Is
and CD4 and CD8 expression. The graph shows the percentage ofExpressed at High levels in DN and CD41 and CD81 SP Thymocytes
viable DP thymocytes in cultures containing dexamethasone relativeand Low Levels in DP Thymocytes
to viable DP thymocytes in cultures containing medium alone. Simi-
(A) NotchIC expression upregulates Deltex expression. AKR1010, lar results were obtained in three independent experiments.
the RH4 dexamethasone-resistant clone, and polyclonal AKR1010
expressing NotchIC were analyzed for Deltex expression by North-
ern blot analysis.
Bcl-2 and Deltex. Similarly, Notch signaling upregulates(B) Expression of Deltex in thymocyte subpopulations. cDNA pre-
pared from FACS-sorted thymocyte subpopulations was serially mNotch-1 expression and DN thymocytes, and CD41 and
diluted at 3-fold and amplified by PCR with primers specific for CD81 SP thymocytes express higher levels of mNotch-1
Deltex. The PCR products were analyzed by Southern blot using a than DP thymocytes. Based on these observations, we
Deltex-specific probe. Amplification of the same cDNA using prim- propose that the activity of the Notch signaling pathway
ers specific for HPRT was performed to control for template quality.
is high in DN and CD41 and CD81 SP thymocytes and
low in DP thymocytes. Furthermore, we suggest that
Notch signaling regulates the expression of multipleDiscussion
genes that are differentially expressed within these thy-
mocyte subsets.Notch is an evolutionarily conserved cell surface recep-
tor that plays a role in many developmental processes. What regulates activation of Notch signaling in devel-
oping thymocytes? In many developmental processes,Upon binding to its ligand, Notch is proteolytically pro-
cessed within the transmembrane domain and the intra- Notch signaling is regulated by cell±cell interactions be-
tween Notch and Notch ligand-expressing cells. Jag-cellular domain is released (Schroeter et al., 1998; Struhl
and Adachi, 1998). Following transport to the nucleus, ged-2, which is a ligand for mNotch-1, is expressed at
high levels in the thymus (Luo et al., 1997), suggestingthe intracellular domain of Notch physically interacts
with the RBP/Su(H) transcription factor and changes that cell±cell interactions between thymocytes and Jag-
ged-2-expressing cells may play a crucial role in regu-RBP/Su(H) from a repressor to an activator of transcrip-
tion (Hsieh et al., 1996; Kao et al., 1998). Notch thereby lating Notch signaling. If interaction with Jagged-2-
expressing cells directly regulates Notch signaling infunctions in a signal transduction pathway that directly
links activation of a cell surface receptor to changes in thymocytes, our data suggests that DN and SP thymo-
cytes, but not DP thymocytes, productively interact withgene expression.
Notch is expressed at high levels in developing thymo- Jagged-2-expressing cells. A characterization of the
pattern of expression of Jagged-2 and other Notch li-cytes (Hasserjian et al., 1996), and a role for Notch sig-
naling in regulating the CD4 versus CD8 cell fate choice gands in the thymus is necessary to test this hypothesis.
An alternative possibility is that Jagged-2 or other Notchhas been proposed (Robey et al., 1996). We have shown
that activation of the Notch signaling pathway in a DP ligands may be ubiquitously expressed in the thymus
and additional factors may regulate activation of thethymoma cell line and in thymocytes results in the induc-
tion of multiple phenotypic changes that are associated Notch signaling pathway. It is intriguing to speculate
that Notch signaling may be regulated, directly or indi-with the differentiation of DP thymocytes into SP thy-
mocytes. These changes include the acquisition of re- rectly, by signals delivered through the pre-TCR and
TCR. These cell surface receptors play a critical role insistance to glucocorticoid-induced apoptosis and the
upregulation of Bcl-2, TCR, and Deltex expression. Fur- regulating the development of thymocytes. Signals from
the pre-TCR are required for the maturation of DN thy-thermore, phenotypes that are associated with active
Notch signaling are present in DN and CD41 and CD81 mocytes into DP thymocytes, and our data suggest that
this is accompanied by the inhibition of Notch signaling.SP thymocytes and absent from DP thymocytes in nor-
mal mice. Thus, both DN and CD41 and CD81 SP thymo- Similarly, the maturation of DP thymocytes into SP thy-
mocytes is dependent upon appropriate signals fromcytes are resistant to glucocorticoids and express high
levels of Bcl-2 and Deltex, whereas DP thymocytes are the TCR and may be accompanied by activation of the
Notch signaling pathway. Changes in the activity of thesensitive to glucocorticoids and express low levels of
Notch Signaling during Thymocyte Development
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Notch signaling pathway that occur concomitant with CD81 SP lineages. Expression of NotchIC under control
thymocyte maturation may be a secondary consequence of the lck proximal promoter may induce maturation of
of maturation or may play an active role in inducing DP thymocytes that have not received appropriate TCR
thymocyte maturation. If Notch plays an active role in and coreceptor signals. Again, since less stringent TCR
driving the maturation of DP thymocytes into SP thymo- signals may be required for commitment to the CD8
cytes, this suggests the possibility that positively select- lineage relative to the CD4 lineage, these cells may pref-
ing TCR signals may facilitate activation of the Notch erentially adopt the CD8 cell fate. According to this
signaling pathway. One important event in this process model, Notch signaling plays a role in the positive selec-
would be the rescue of DP thymocytes from glucocorti- tion of DP thymocytes, but different factors, most likely
coid-induced apoptosis. Interestingly, we have identi- signals derived from the interaction of the TCR and CD4
fied Deltex as a gene whose expression is upregulated or CD8 coreceptor molecules with MHC ligands, drive
by Notch signaling in T cells. Deltex was originally identi- lineage commitment. The excess CD81 SP cells that
fied in Drosophila as a gene that genetically interacts appear in the thymus of Bcl-2 and NotchIC transgenic
with the Notch signaling pathway (Xu and Artavanis, mice are not seen in the lymphoid periphery (Sentman
1990). Ectopic expression of Deltex in Drosophila results et al., 1991; Robey et al., 1996). Either they die within
in phenotypes similar to those that result from expres- the thymus or shortly after leaving. Both models we
sion of constitutively active Notch (Matsuno et al., 1995). have suggested above imply that these cells have not
This suggests that Deltex functions to positively regulate received appropriate positively selecting signals for
the Notch signaling pathway. If murine Deltex functions maturation and may be only partially along the pathway
similarly, this suggests a positive feedback loop in which to full maturity. In line with this idea, the excess CD81
initial activation of Notch signaling is positively rein- SP thymocytes in the NotchIC-9 mice express lower
forced by the upregulation of Deltex expression. levels of CD8 and TCR than wild-type CD81 SP thymo-
Our model differs from a previous model suggesting cytes (data not shown).
that the Notch signaling pathway functions to regulate The ability of NotchIC to induce multiple phenotypic
the CD4 versus CD8 lineage choice (Robey et al., 1996). changes in the AKR1010 cell line that are associated with
This model was based on the observation that expres- the maturation of DP thymocytes into SP thymocytes
sion of NotchIC under control of the lck proximal pro- provides a useful system for studying molecular events
moter in transgenic mice leads to the development of that occur during thymocyte development. Our data
an excess of CD81 SP thymocytes over CD41 SP thymo- suggest that the Notch signaling pathway regulates the
cytes. This led to the hypothesis that positively selected expression of genes that confer resistance to glucocorti-
DP thymocytes that receive a Notch signal develop into coids and upregulate TCR surface expression in thymo-
CD81 SP thymocytes, whereas, in the absence of Notch cytes. Mechanisms regulating glucocorticoid-sensitivity
signals, DP thymocytes adopt the CD41 cell fate. We and TCR surface expression in developing thymocytes
note, however, that mice expressing Bcl-2 as a trans- are not known (Cohen, 1992; Kearse et al., 1995). The
gene under control of the lck proximal promoter have identification of genes regulated by Notch signaling in
a very similar phenotype to the NotchIC transgenic mice. AKR1010 and other T cell lines may provide a productive
Both types of transgenic mice develop an excess of approach toward elucidating the molecular basis for
CD81 SP thymocytes that express high levels of TCR these and other events of thymocyte maturation.
but do not survive in the periphery, and in both cases
the development in these CD81 SP thymocytes is inde-
pendent of MHC class I expression but does depend Experimental Procedures
on some MHC expression, either class I or class II (Sent-
Cell Lines and Tissue Cultureman et al., 1991; Linette et al., 1994; Robey et al., 1996).
AKR1010 is a spontaneous CD41CD81 thymoma cell line derivedWhy do both the Bcl-2 and NotchIC transgenic mice
from an AKR/J mouse (Richie et al., 1988). 2B4.11 is a T cell hybrid-develop excess CD81 SP thymocytes? As we have
oma specific for pigeon cytochrome C (Ashwell et al., 1987). FNX-Ashown for the NotchIC transgene, the Bcl-2 transgene
is a retrovirus packaging cell line that produces high-titer ampho-
also renders DP thymocytes resistant to the apoptotic tropic retrovirus upon transient transfection (Pear, 1996). All cells
effects of glucocorticoids (Sentman et al., 1991; Strasser were cultured in DMEM containing 10% FCS, 2 mM glutamine, 25
et al., 1991; Siegel et al., 1992), and the preferential mM HEPES, 50 mM b-mercaptoethanol, 100 U/ml penicillin, and 100
mg/ml streptomycin. Dexamethasone was purchased from Sigma.effect of NotchIC and Bcl-2 on CD81 SP thymocyte
development may be secondary to this effect. Enhanced
survival in the presence of endogenous glucocorticoids
Thymocyte cDNA Library Construction
may allow DP thymocytes a greater chance to interact PolyA1 RNA was prepared from thymocytes from 6- to 8-week-
with positively selecting MHC ligands. Since CD8 lin- old female C57BL/6 mice using the FastTrack 2.0 kit (Invitrogen).
eage commitment may require weaker signals from the Double-stranded cDNA was synthesized using random hexamer or
oligo dT primers, size selected, and ligated into the BstXI site ofTCR compared to the signal strength needed for CD4
the pMX vector (Onishi et al., 1996). The ligation reaction was trans-lineage commitment (Itano et al., 1996; Matechak et al.,
formed into ElectroMAX DH10B E. coli (GIBCO-BRL) and plated1996), then cells which have an extremely low affinity
onto multiple LB plates containing 100 mg/ml ampicillin. Approxi-interaction with self-MHC, and which would normally
mately 1 3 107 independent clones were obtained from 2 mg of
die by neglect, may be rescued preferentially to the CD8 polyA1 RNA. These clones were pooled and plasmid DNA prepared
lineage in the Bcl-2 and NotchIC mice. Alternatively, using the Qiagen Plasmid Maxi Kit. Two random hexamer primed
Notch signaling may play an active role in driving the libraries (RH and US) and one oligo-dT primed library (OT) were
constructed.maturation of DP thymocytes into both the CD41 and
Immunity
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Retrovirus Production and Infection of T Cell Lines of debris by centrifugation. 2 3 106 cell equivalents were separated
on polyacrylamide gels, transferred to nitrocellulose, and probedPlasmid DNA was transfected into the FNX-A packaging cell line
using CaPO4 precipitation as described (Pear, 1996). Retrovirus- with the antibodies to mNotch-1 (C-20, Santa Cruz), Bcl-2 (3F11,
Pharmingen), or Bcl-XL (S-18, Santa Cruz). Bound antibodies werecontaining supernatant was collected following overnight incubation
of the transfected packaging cells at 328C. AKR1010 and 2B4.11 detected with HRP-conjugated secondary antibodies and enhanced
chemiluminesence according to the manufacturer's instructionscells were infected by resuspending mid-log phase cells at 5 3 105
cells/ml in retrovirus-containing supernatant supplemented with 8 (Amersham).
mg/ml polybrene followed by centrifugation for 90 min at 2500 rpm
and overnight incubation at 328C. Representation Difference Analysis and Northern
Blot Analysis
Expression Cloning RDA was performed as described (Hubank and Schatz, 1994) using
Retrovirus-containing supernatant was prepared from the RH, US, cDNA prepared from AKR1010 as ªdriverº and cDNA prepared from
and OT thymocyte cDNA libraries and used to infect 2 3 107 the RH4 dexamethasone-resistant clone as ªtester.º Multiple dis-
AKR1010 cells. Two days following infection, dexamethasone was tinct products were observed by agarose gel electrophoresis follow-
added to the cultures at a final concentration of 1026 M and the ing two rounds of subtractive PCR. Sequence analysis of these
cells were plated at 1 3 104 cells per well in 96-well plates. Culture products revealed multiple DpnII fragments derived from the murine
for 2±4 weeks in the presence of dexamethasone resulted in the Deltex gene (Pampeno and Meruelo, 1996). Northern blot analysis
isolation of numerous dexamethasone-resistant clones. RT-PCR us- was performed according to standard protocols (Sambrook et al.,
ing vector-specific primers that flank the polycloning site of pMX 1989). 10 mg of total RNA from each cell line was analyzed. Equiva-
was used to amplify cDNA prepared from the dexamethasone-resis- lent loading and transfer was verified by visual inspection of ribo-
tant clones. PCR products were purified and directly sequenced with somal RNA bands. The probe consisted of a cloned fragment of
nested vector-specific primers on an ABI automated sequencer. murine Deltex corresponding to nucleotides 1028 to 1938.
Construction of NotchIC Plasmids and Generation
RT-PCR Analysis of Thymocyte Subsetsof Transgene-Expressing Polyclonal Cell Lines
Thymocytes from 6- to 8-week-old C57BL/6 mice were sorted forThe pMI vector was constructed by cloning the internal ribosome
DN, DP, CD41 SP, and CD81 SP subsets by FACS. Following sorting,entry site (IRES) from the encephalomyocarditis virus and a cDNA
each subset contained less than 0.5% contamination with otherencoding the extracellular and transmembrane domains of human
sorted subsets. RNA prepared from sorted cells was converted intoCD2 into the pMX vector. The resulting vector contains a polycloning
cDNA and used as a template for PCR. Sequences of primers usedsite upstream of an IRES-hCD2 cassette. cDNA cloned into this
for Deltex amplification are 59CACTGGCCCTGTCCACCCAGCCTTGvector is transcribed into bicistronic mRNA that concomitantly di-
GCAGG39 and 59ATGCGAATTCGGGAAGGCGGGCAACTCAGG39.rects translation of the cDNA and hCD2. pMI-based plasmids used
PCR reactions were prepared according to manufacturer instruc-in this work include the following: pMI/NotchIC contains a Kozak
tions (Perkin Elmer) and consisted of 30 cycles (45 sec 948C, 45consensus initiation methionine followed by the coding region of
sec 558C, and 60 sec 728C). The PCR products were analyzed bymNotch-1 extending from amino acids 1751 to 2444; pMI/NotchIC/
Southern blot using standard protocols (Sambrook et al., 1989). ThemM2-2 is identical to pMI/NotchIC except that it contains the mM2-2
probe consisted of a cloned fragment of murine Deltex correspond-point mutations in the RAM domain (Tamura et al., 1995); pMI/
ing to nucleotides 1028 to 1938.NotchIC/DAnk contains a Kozak consensus initiation methionine
followed by the coding region of mNotch-1 extending from amino
Analysis of Thymocyte Sensitivity to Glucocorticoidsacids 1941 to 2444. The mNotch-1 cDNA used to generate these
Thymocytes from NotchIC-9 transgenic and littermate control miceconstructs was obtained by RT-PCR from the RH4 dexamethasone-
were incubated at 3 3 106 cell/ml in medium alone or in mediumresistant clone using Pfu polymerase (Stratagene). Polyclonal cell
supplemented with 1028 M dexamethasone. After the indicatedlines expressing various Notch polypeptides were generated by
times, the cells were harvested, stained with antibodies specific forinfecting AKR1010 and 2B4.11 with retrovirus produced from the
CD4 and CD8, and 50,000 events analyzed by FACS. A viable cellpMI/NotchIC, pMI/NotchIC/mM2-2, and pMI/NotchIC/DAnk plas-
gate was established based on FSC and SSC, and the number ofmids. Following infection, transgene-expressing cells were isolated
CD41CD81 events falling in the viable gate was used to quantitateby multiple rounds of panning on tissue culture plates coated with
the number of viable DP cells. The percentage of relative survival50 mg/ml anti-hCD2 antibody (MAb 35.1). Control cells were similarly
was calculated by dividing the number of viable DP thymocytes ingenerated by using retrovirus produced from the control pMI vector.
cultures containing dexamethasone by the number of viable DP
thymocytes in cultures containing medium alone.Flow Cytometric Analysis
Cells were incubated with an excess of labeled antibodies on ice
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incubated in triplicate in 96-well plates at 1 3 104 cells/well in media
Received September 15, 1998; revised October 18, 1998.
or media containing various concentrations (1 3 10210 M to 1 3 1026
M) of dexamethasone for 24 hr followed by the addition of 1 mCi
Referencesof 3H thymidine. After an additional 12 hr, the cells were harvested
and incorporated thymidine measured.
Artavanis, T.S., Matsuno, K., and Fortini, M.E. (1995). Notch signal-
ing. Science 268, 225±232.Western Blot Analysis
Cells were lysed at 1 3 108 cells/ml in lysis buffer (50 mM Tris [pH Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D.
(1987). Cell growth cycle block of T cell hybridomas upon activation7.6], 150 mM NaCl, 1 mM EDTA, 1% NP-40 containing 1 mM PMSF,
10 mg/ml aprotinin, and 10 mg/ml pepstatin) for 30 min and cleared with antigen. J. Exp. Med. 165, 173±194.
Notch Signaling during Thymocyte Development
785
Beato, M., Herrlich, P., and Schutz, G. (1995). Steroid hormone re- MHC class II-specific T cells can develop in the CD8 lineage when
CD4 is absent. Immunity 4, 337±347.ceptors: many actors in search of a plot. Cell 83, 851±857.
Matsuno, K., Diederich, R.J., Go, M.J., Blaumueller, C.M., and Arta-Blaumueller, C.M., Qi, H., Zagouras, P., and Artavanis, T.S. (1997).
vanis, T.S. (1995). Deltex acts as a positive regulator of Notch signal-Intracellular cleavage of Notch leads to a heterodimeric receptor
ing through interactions with the Notch ankyrin repeats. Develop-on the plasma membrane. Cell 90, 281±291.
ment 121, 2633±2644.Chao, D.T., Linette, G.P., Boise, L.H., White, L.S., Thompson, C.B.,
Matsuno, K., Go, M.J., Sun, X., Eastman, D.S., and Artavanis, T.S.and Korsmeyer, S.J. (1995). Bcl-XL and Bcl-2 repress a common
(1997). Suppressor of Hairless-independent events in Notch signal-pathway of cell death. J. Exp. Med. 182, 821±828.
ing imply novel pathway elements. Development 124, 4265±4273.Cohen, J.J. (1992). Glucocorticoid-induced apoptosis in the thymus.
Matsuno, K., Eastman, D., Mitsiades, T., Quinn, A.M., Carcanciu,Semin. Immunol. 4, 363±369.
M.L., Ordentlich, P., Kadesch, T., and Artavanis, T.S. (1998). HumanCohen, J.J., and Duke, R.C. (1984). Glucocorticoid activation of a
deltex is a conserved regulator of Notch signaling. Nat. Genet. 19,
calcium-dependent endonuclease in thymocyte nuclei leads to cell
74±78.
death. J. Immunol. 132, 38±42.
Miyashita, T., and Reed, J.C. (1992). bcl-2 gene transfer increases
del Amo, F.F., Gendron, M.M., Swiatek, P.J., Jenkins, N.A., Cope-
relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death
land, N.G., and Gridley, T. (1993). Cloning, analysis, and chromo- and DNA fragmentation induced by glucocorticoids and multiple
somal localization of Notch-1, a mouse homolog of Drosophila chemotherapeutic drugs. Cancer Res. 52, 5407±5411.
Notch. Genomics 15, 259±264.
Onishi, M., Kinoshita, S., Morikawa, Y., Shibuya, A., Phillips, J., La-
Grillot, D.A., Merino, R., and Nunez, G. (1995). Bcl-XL displays re- nier, L.L., Gorman, D.M., Nolan, G.P., Miyajima, A., and Kitamura,
stricted distribution during T cell development and inhibits multiple T. (1996). Applications of retrovirus-mediated expression cloning.
forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Hematol. 24, 324±329.
Exp. Med. 182, 1973±1983.
Pampeno, C.L., and Meruelo, D. (1996). A novel cDNA transcript
Hasserjian, R.P., Aster, J.C., Davi, F., Weinberg, D.S., and Sklar, J. expressed in fractionated X-irradiation-induced murine thymomas.
(1996). Modulated expression of notch1 during thymocyte develop- Cell Growth Differ. 7, 1113±1123.
ment. Blood 88, 970±976.
Pear, W. (1996). Transient transfection methods for preparation of
Hsieh, J.J., Henkel, T., Salmon, P., Robey, E., Peterson, M.G., and high-titer retroviral supernatants. In Current Protocols in Molecular
Hayward, S.D. (1996). Truncated mammalian Notch1 activates Biology, F.M. Auaubel, R. Brent, R.E. Kingston, D.D. Moore, J.G.
CBF1/RBPJk-repressed genes by a mechanism resembling that of Seidman, J.A. Smith, and K. Struhl, eds. (New York: John Wiley and
Epstein-Barr virus EBNA2. Mol. Cell. Biol. 16, 952±959. Sons, Inc.), pp. 9±11.
Hubank, M., and Schatz, D.G. (1994). Identifying differences in Rebay, I., Fehon, R.G., and Artavanis, T.S. (1993). Specific trunca-
mRNA expression by representational difference analysis of cDNA. tions of Drosophila Notch define dominant activated and dominant
Nucleic Acids Res. 22, 5640±5648. negative forms of the receptor. Cell 74, 319±329.
Itano, A., Salmon, P., Kioussis, D., Tolaini, M., Corbella, P., and Reichardt, H., Kaestner, K., Tuckermann, J., Kretz, O., Wessely, O.,
Robey, E. (1996). The cytoplasmic domain of CD4 promotes the Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz,
development of CD4 lineage T cells. J. Exp. Med. 183, 731±741. G. (1998). DNA binding of the glucocorticoid receptor is not essential
for survival. Cell 93, 531±541.Jameson, S., and Bevan, M. (1998). T-cell selection. Curr. Opin.
Richie, E.R., McEntire, B., Crispe, N., Kimura, J., Lanier, L.L., andImmunol. 10, 214±219.
Allison, J.P. (1988). Alpha/beta T-cell antigen receptor gene andKao, H.Y., Ordentlich, P., Koyano, N.N., Tang, Z., Downes, M., Kint-
protein expression occurs at early stages of thymocyte differentia-ner, C.R., Evans, R.M., and Kadesch, T. (1998). A histone deacetylase
tion. Proc. Natl. Acad. Sci. USA 85, 1174±1178.corepressor complex regulates the Notch signal transduction path-
Robey, E., Chang, D., Itano, A., Cado, D., Alexander, H., Lans, D.,way. Genes Dev. 12, 2269±2277.
Weinmaster, G., and Salmon, P. (1996). An activated form of NotchKato, H., Taniguchi, Y., Kurooka, H., Minoguchi, S., Sakai, T., No-
influences the choice between CD4 and CD8 T cell lineages. Cellmura, O.S., Tamura, K., and Honjo, T. (1997). Involvement of RBP-J
87, 483±492.in biological functions of mouse Notch1 and its derivatives. Develop-
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Clon-ment 124, 4133±4141.
ing: A Laboratory Manual, Second Edition (Cold Spring Harbor, NY:Kearse, K.P., Roberts, J.P., Wiest, D.L., and Singer, A. (1995). Devel-
Cold Spring Harbor Laboratory Press).opmental regulation of alpha beta T cell antigen receptor assembly
Schroeter, E.H., Kisslinger, J.A., and Kopan, R. (1998). Notch-1 sig-in immature CD41CD81 thymocytes. Bioessays 17, 1049±1054.
naling requires ligand-induced proteolytic release of intracellularKisielow, P., and von Boehmer, H. (1995). Development and selec-
domain. Nature 393, 382±386.tion of T cells: facts and puzzles. Adv. Immunol. 58, 87±209.
Scollay, R., Bartlett, P., and Shortman, K. (1984). T cell developmentKopan, R., Schroeter, E.H., Weintraub, H., and Nye, J.S. (1996).
in the adult murine thymus: changes in the expression of the surfaceSignal transduction by activated mNotch: importance of proteolytic
antigens Ly2, L3T4 and B2A2 during development from early precur-processing and its regulation by the extracellular domain. Proc. Natl.
sor cells to emigrants. Immunol. Rev. 82, 79±103.
Acad. Sci. USA 93, 1683±1688.
Screpanti, I., Morrone, S., Meco, D., Santoni, A., Gulino, A., Paolini,
Lieber, T., Kidd, S., Alcamo, E., Corbin, V., and Young, M.W. (1993).
R., Crisanti, A., Mathieson, B.J., and Frati, L. (1989). Steroid sensitiv-
Antineurogenic phenotypes induced by truncated Notch proteins
ity of thymocyte subpopulations during intrathymic differentiation.
indicate a role in signal transduction and may point to a novel func-
Effects of 17 beta-estradiol and dexamethasone on subsets ex-
tion for Notch in nuclei. Genes Dev. 7, 1949±1965.
pressing T cell antigen receptor or IL-2 receptor. J. Immunol. 142,
Linette, G.P., Grusby, M.J., Hedrick, S.M., Hansen, T.H., Glimcher, 3378±3383.
L.H., and Korsmeyer, S.J. (1994). Bcl-2 is upregulated at the CD41 Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O., and
CD81 stage during positive selection and promotes thymocyte dif- Korsmeyer, S.J. (1991). bcl-2 inhibits multiple forms of apoptosis
ferentiation at several control points. Immunity 1, 197±205. but not negative selection in thymocytes. Cell 67, 879±888.
Lucas, B., and Germain, R.N. (1996). Unexpectedly complex regula- Shawber, C., Nofziger, D., Hsieh, J.J., Lindsell, C., Bogler, O., Hay-
tion of CD4/CD8 coreceptor expression supports a revised model ward, D., and Weinmaster, G. (1996). Notch signaling inhibits muscle
for CD41CD81 thymocyte differentiation. Immunity 5, 461±477. cell differentiation through a CBF1-independent pathway. Develop-
Luo, B., Aster, J.C., Hasserjian, R.P., Kuo, F., and Sklar, J. (1997). ment 122, 3765±3773.
Isolation and functional analysis of a cDNA for human Jagged2, a Siegel, R.M., Katsumata, M., Miyashita, T., Louie, D.C., Greene, M.I.,
gene encoding a ligand for the Notch1 receptor. Mol. Cell. Biol. 17, and Reed, J.C. (1992). Inhibition of thymocyte apoptosis and nega-
6057±6067. tive antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad.
Sci. USA 89, 7003±7007.Matechak, E.O., Killeen, N., Hedrick, S.M., and Fowlkes, B.J. (1996).
Immunity
786
Sprent, J., Lo, D., Gao, E.K., and Ron, Y. (1988). T cell selection in
the thymus. Immunol. Rev. 101, 173±190.
Strasser, A., Harris, A.W., and Cory, S. (1991). bcl-2 transgene inhib-
its T cell death and perturbs thymic self-censorship. Cell 67,
889±899.
Struhl, G., and Adachi, A. (1998). Nuclear access and action of notch
in vivo. Cell 93, 649±660.
Struhl, G., Fitzgerald, K., and Greenwald, I. (1993). Intrinsic activity of
the Lin-12 and Notch intracellular domains in vivo. Cell 74, 331±345.
Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furu-
kawa, T., and Honjo, T. (1995). Physical interaction between a novel
domain of the receptor Notch and the transcription factor RBP-J
kappa/Su(H). Curr. Biol. 5, 1416±1423.
Vacchio, M.S., Ashwell, J.D., and King, L.B. (1998). A positive role
for thymus-derived steroids in formation of the T-cell repertoire.
Ann. NY Acad. Sci. 840, 317±327.
Veis, D.J., Sentman, C.L., Bach, E.A., and Korsmeyer, S.J. (1993).
Expression of the Bcl-2 protein in murine and human thymocytes
and in peripheral T lymphocytes. J. Immunol. 151, 2546±2554.
Weinmaster, G. (1997). The ins and outs of notch signaling. Mol.
Cell. Neurosci. 9, 91±102.
Wettstein, D.A., Turner, D.L., and Kintner, C. (1997). The Xenopus
homolog of Drosophila Suppressor of Hairless mediates Notch sig-
naling during primary neurogenesis. Development 124, 693±702.
Wilkinson, H.A., Fitzgerald, K., and Greenwald, I. (1994). Reciprocal
changes in expression of the receptor lin-12 and its ligand lag-2
prior to commitment in a C. elegans cell fate decision. Cell 79,
1187±1198.
Wyllie, A.H., Morris, R.G., Smith, A.L., and Dunlop, D. (1984). Chro-
matin cleavage in apoptosis: association with condensed chromatin
morphology and dependence on macromolecular synthesis. J. Pa-
thol. 142, 67±77.
Xu, T., and Artavanis, T.S. (1990). deltex, a locus interacting with
the neurogenic genes, Notch, Delta and mastermind in Drosophila
melanogaster. Genetics 126, 665±677.
Zacharchuk, C.M., Mer'cep, M., Chakraborti, P.K., Simons, S.S.J.,
and Ashwell, J.D. (1990). Programmed T lymphocyte death. Cell
activation- and steroid-induced pathways are mutually antagonistic.
J. Immunol. 145, 4037±4045.
